Becton, Dickinson and Company (BDX) Competitors

Becton, Dickinson and Company logo
$216.33 -1.70 (-0.78%)
Closing price 03:59 PM Eastern
Extended Trading
$217.28 +0.95 (+0.44%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BDX vs. COO, HSIC, IDXX, AMN, and CAH

Should you buy Becton, Dickinson and Company stock or one of its competitors? Becton, Dickinson and Company's main competitors and comparable companies include Cooper Companies (COO), Henry Schein (HSIC), IDEXX Laboratories (IDXX), AMN Healthcare Services (AMN), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Becton, Dickinson and Company compare to Cooper Companies?

Becton, Dickinson and Company (NYSE:BDX) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$19.46B3.09$1.15B$4.1452.64
Cooper Companies$4.24B2.81$374.90M$2.9321.38

Becton, Dickinson and Company has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cooper Companies has a net margin of 13.46% compared to Becton, Dickinson and Company's net margin of 5.66%. Becton, Dickinson and Company's return on equity of 14.90% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company5.66% 14.90% 7.09%
Cooper Companies 13.46%10.90%7.24%

In the previous week, Cooper Companies had 1 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 23 mentions for Cooper Companies and 22 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 0.77 beat Cooper Companies' score of 0.54 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
10 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
8 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
5 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company presently has a consensus price target of $197.47, indicating a potential downside of 9.40%. Cooper Companies has a consensus price target of $68.60, indicating a potential upside of 9.50%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50
Cooper Companies
3 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.05

Summary

Becton, Dickinson and Company beats Cooper Companies on 10 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Henry Schein?

Becton, Dickinson and Company (NYSE:BDX) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Becton, Dickinson and Company has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Becton, Dickinson and Company has a net margin of 5.66% compared to Henry Schein's net margin of 3.07%. Henry Schein's return on equity of 16.39% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company5.66% 14.90% 7.09%
Henry Schein 3.07%16.39%5.58%

In the previous week, Becton, Dickinson and Company had 21 more articles in the media than Henry Schein. MarketBeat recorded 22 mentions for Becton, Dickinson and Company and 1 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.89 beat Becton, Dickinson and Company's score of 0.77 indicating that Henry Schein is being referred to more favorably in the news media.

Company Overall Sentiment
Becton, Dickinson and Company Positive
Henry Schein Positive

Becton, Dickinson and Company has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$19.46B3.09$1.15B$4.1452.64
Henry Schein$13.18B0.72$398M$3.6523.62

Becton, Dickinson and Company currently has a consensus target price of $197.47, indicating a potential downside of 9.40%. Henry Schein has a consensus target price of $93.57, indicating a potential upside of 8.53%. Given Henry Schein's higher probable upside, analysts plainly believe Henry Schein is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50
Henry Schein
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Becton, Dickinson and Company beats Henry Schein on 8 of the 15 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

IDEXX Laboratories has a net margin of 25.36% compared to Becton, Dickinson and Company's net margin of 5.66%. IDEXX Laboratories' return on equity of 71.04% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
IDEXX Laboratories25.36% 71.04% 33.99%
Becton, Dickinson and Company 5.66%14.90%7.09%

In the previous week, Becton, Dickinson and Company had 14 more articles in the media than IDEXX Laboratories. MarketBeat recorded 22 mentions for Becton, Dickinson and Company and 8 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.27 beat Becton, Dickinson and Company's score of 0.77 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEXX Laboratories
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
10 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDEXX Laboratories$4.30B12.89$1.06B$14.8347.49
Becton, Dickinson and Company$19.46B3.09$1.15B$4.1452.64

IDEXX Laboratories presently has a consensus target price of $717.27, indicating a potential upside of 1.85%. Becton, Dickinson and Company has a consensus target price of $197.47, indicating a potential downside of 9.40%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, equities analysts plainly believe IDEXX Laboratories is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50

IDEXX Laboratories has a beta of 1.55, meaning that its share price is 55% more volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

IDEXX Laboratories beats Becton, Dickinson and Company on 12 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Becton, Dickinson and Company (NYSE:BDX) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

Becton, Dickinson and Company has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.54-$95.70M$2.7513.84
Becton, Dickinson and Company$19.46B3.09$1.15B$4.1452.64

AMN Healthcare Services has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AMN Healthcare Services presently has a consensus target price of $39.17, suggesting a potential upside of 2.94%. Becton, Dickinson and Company has a consensus target price of $197.47, suggesting a potential downside of 9.40%. Given AMN Healthcare Services' higher possible upside, equities research analysts clearly believe AMN Healthcare Services is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Becton, Dickinson and Company had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 22 mentions for Becton, Dickinson and Company and 8 mentions for AMN Healthcare Services. Becton, Dickinson and Company's average media sentiment score of 0.77 beat AMN Healthcare Services' score of 0.47 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Becton, Dickinson and Company
10 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has a net margin of 5.66% compared to AMN Healthcare Services' net margin of 3.10%. AMN Healthcare Services' return on equity of 23.42% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.10% 23.42% 7.19%
Becton, Dickinson and Company 5.66%14.90%7.09%

Summary

Becton, Dickinson and Company beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cardinal Health has higher revenue and earnings than Becton, Dickinson and Company. Cardinal Health is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$254.25B0.26$1.71B$7.7336.42
Becton, Dickinson and Company$19.46B3.09$1.15B$4.1452.64

Cardinal Health currently has a consensus price target of $279.44, indicating a potential downside of 0.75%. Becton, Dickinson and Company has a consensus price target of $197.47, indicating a potential downside of 9.40%. Given Cardinal Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Cardinal Health is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.89
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50

Cardinal Health has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market.

In the previous week, Cardinal Health had 1 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 23 mentions for Cardinal Health and 22 mentions for Becton, Dickinson and Company. Cardinal Health's average media sentiment score of 0.83 beat Becton, Dickinson and Company's score of 0.77 indicating that Cardinal Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
10 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
10 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has a net margin of 5.66% compared to Cardinal Health's net margin of 0.71%. Becton, Dickinson and Company's return on equity of 14.90% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.71% -102.72% 4.86%
Becton, Dickinson and Company 5.66%14.90%7.09%

Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.7%. Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 1.9%. Cardinal Health pays out 26.6% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 101.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cardinal Health has increased its dividend for 29 consecutive years and Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cardinal Health beats Becton, Dickinson and Company on 12 of the 19 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDX vs. The Competition

MetricBecton, Dickinson and CompanyHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$59.44B$5.97B$7.83B$23.17B
Dividend Yield1.95%1.68%2.47%3.79%
P/E Ratio16.3539.0934.3429.41
Price / Sales3.064.848.003.27
Price / Cash10.2624.1821.0215.64
Price / Book2.414.954.764.04
Net Income$1.15B$143.12M$3.52B$1.07B
7 Day Performance0.56%-4.86%-5.34%-3.09%
1 Month Performance13.06%-2.87%-3.61%-1.21%
1 Year Performance12.13%-0.76%0.01%5.63%

Becton, Dickinson and Company Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
3.7894 of 5 stars
$216.33
-0.8%
$197.47
-8.7%
+13.0%$59.44B$19.46B16.3572,000
COO
Cooper Companies
3.5182 of 5 stars
$63.93
+2.5%
$68.60
+7.3%
-13.1%$12.25B$4.09B21.8215,000
HSIC
Henry Schein
2.3209 of 5 stars
$88.41
+2.7%
$93.57
+5.8%
+20.7%$9.75B$13.18B24.2225,000
IDXX
IDEXX Laboratories
2.3563 of 5 stars
$706.65
+4.5%
$719.55
+1.8%
+2.1%$55.04B$4.30B47.2011,000
AMN
AMN Healthcare Services
1.9914 of 5 stars
$38.00
+5.0%
$39.17
+3.1%
+140.4%$1.85B$2.73B13.722,664

Related Companies and Tools


This page (NYSE:BDX) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners